BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.370
-0.024 (-6.19%)
At close: Jun 26, 2026, 4:00 PM EDT
0.379
+0.009 (2.54%)
After-hours: Jun 26, 2026, 7:32 PM EDT
BioRestorative Therapies Employees
As of December 31, 2025, BioRestorative Therapies had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$25,562
Profits / Employee
-$789,756
Market Cap
9.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| Jasper Therapeutics | 22 |
| Kiora Pharmaceuticals | 13 |
| Psyence Biomedical | 12 |
| Aprea Therapeutics | 8 |
| Ernexa Therapeutics | 7 |
| Intensity Therapeutics | 7 |
| Quoin Pharmaceuticals | 6 |
BRTX News
- 3 days ago - BioRestorative Therapies completes manufacturing for BRTX-100 - TheFly
- 3 days ago - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform - GlobeNewsWire
- 10 days ago - BioRestorative Therapies appoints Smith as VP of Biocosmeceuticals Division - TheFly
- 10 days ago - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - GlobeNewsWire
- 25 days ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 4 weeks ago - BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake - TheFly
- 4 weeks ago - Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - PRNewsWire
- 4 weeks ago - BioRestorative Therapies completes Phase 2 dosing of BRTX-100 - TheFly